Annual CFI:
-$299.48M-$260.23M(-662.86%)Summary
- As of today, PTGX annual cash from investing is -$299.48 million, with the most recent change of -$260.23 million (-662.86%) on December 31, 2024.
- During the last 3 years, PTGX annual cash from investing has fallen by -$283.62 million (-1788.29%).
- PTGX annual cash from investing is now -427.42% below its all-time high of $91.47 million, reached on December 31, 2022.
Performance
PTGX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
$54.81M+$149.21M(+158.06%)Summary
- As of today, PTGX quarterly cash from investing is $54.81 million, with the most recent change of +$149.21 million (+158.06%) on June 30, 2025.
- Over the past year, PTGX quarterly cash from investing has increased by +$142.93 million (+162.20%).
- PTGX quarterly cash from investing is now -4.30% below its all-time high of $57.27 million, reached on September 30, 2022.
Performance
PTGX Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$257.03M+$142.93M(+35.74%)Summary
- As of today, PTGX TTM cash from investing is -$257.03 million, with the most recent change of +$142.93 million (+35.74%) on June 30, 2025.
- Over the past year, PTGX TTM cash from investing has dropped by -$100.13 million (-63.82%).
- PTGX TTM cash from investing is now -322.73% below its all-time high of $115.40 million, reached on September 30, 2022.
Performance
PTGX TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PTGX Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | -662.9% | +162.2% | -63.8% |
3Y3 Years | -1788.3% | +57.8% | -2015.5% |
5Y5 Years | -457.6% | +1160.0% | -782.7% |
PTGX Cash From Investing Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -427.4% | at low | -4.3% | +126.3% | -322.7% | +35.7% |
5Y | 5-Year | -427.4% | at low | -4.3% | +126.3% | -322.7% | +35.7% |
All-Time | All-Time | -427.4% | at low | -4.3% | +126.3% | -322.7% | +35.7% |
PTGX Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $54.81M(+158.1%) | -$257.03M(+35.7%) |
Mar 2025 | - | -$94.40M(-982.0%) | -$399.96M(-33.5%) |
Dec 2024 | -$299.48M(-662.9%) | -$8.72M(+95.8%) | -$299.48M(+14.9%) |
Sep 2024 | - | -$208.71M(-136.9%) | -$352.05M(-124.4%) |
Jun 2024 | - | -$88.12M(-1551.5%) | -$156.89M(-264.8%) |
Mar 2024 | - | $6.07M(+109.9%) | -$43.01M(-9.6%) |
Dec 2023 | -$39.26M(-142.9%) | -$61.29M(-352.0%) | -$39.26M(-251.2%) |
Sep 2023 | - | -$13.56M(-152.6%) | $25.96M(-73.2%) |
Jun 2023 | - | $25.76M(+162.2%) | $96.80M(-8.5%) |
Mar 2023 | - | $9.83M(+149.7%) | $105.77M(+15.6%) |
Dec 2022 | $91.47M(+676.7%) | $3.94M(-93.1%) | $91.47M(-20.7%) |
Sep 2022 | - | $57.27M(+64.9%) | $115.40M(+760.0%) |
Jun 2022 | - | $34.73M(+876.0%) | $13.42M(+199.1%) |
Mar 2022 | - | -$4.48M(-116.1%) | -$13.54M(+14.6%) |
Dec 2021 | -$15.86M(+82.6%) | $27.87M(+162.3%) | -$15.86M(+86.6%) |
Sep 2021 | - | -$44.71M(-675.2%) | -$118.13M(+7.4%) |
Jun 2021 | - | $7.77M(+214.4%) | -$127.54M(+9.2%) |
Mar 2021 | - | -$6.79M(+90.9%) | -$140.49M(-54.4%) |
Dec 2020 | -$90.97M | -$74.40M(-37.5%) | -$90.97M(-212.4%) |
Sep 2020 | - | -$54.12M(-946.6%) | -$29.12M(-313.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2020 | - | -$5.17M(-112.1%) | -$7.03M(+53.4%) |
Mar 2020 | - | $42.73M(+440.4%) | -$15.09M(+71.9%) |
Dec 2019 | -$53.71M(-2527.0%) | -$12.55M(+60.8%) | -$53.71M(-46.7%) |
Sep 2019 | - | -$32.04M(-142.3%) | -$36.61M(-784.4%) |
Jun 2019 | - | -$13.22M(-421.9%) | $5.35M(-81.0%) |
Mar 2019 | - | $4.11M(-9.7%) | $28.16M(+1172.7%) |
Dec 2018 | $2.21M(-86.0%) | $4.55M(-54.1%) | $2.21M(-8.4%) |
Sep 2018 | - | $9.92M(+3.4%) | $2.42M(+129.2%) |
Jun 2018 | - | $9.59M(+143.9%) | -$8.27M(-73.4%) |
Mar 2018 | - | -$21.84M(-559.7%) | -$4.77M(-130.2%) |
Dec 2017 | $15.82M(+126.7%) | $4.75M(+715.5%) | $15.82M(+129.7%) |
Sep 2017 | - | -$772.00K(-105.9%) | -$53.25M(-9.6%) |
Jun 2017 | - | $13.09M(+1147.4%) | -$48.60M(+28.2%) |
Mar 2017 | - | -$1.25M(+98.1%) | -$67.72M(-14.2%) |
Dec 2016 | -$59.33M(-617.9%) | -$64.33M(-1756.2%) | -$59.33M(-1821.2%) |
Sep 2016 | - | $3.88M(+164.4%) | -$3.09M(+55.7%) |
Jun 2016 | - | -$6.03M(-184.4%) | -$6.97M(-643.3%) |
Mar 2016 | - | $7.15M(+188.4%) | -$938.00K(+88.4%) |
Dec 2015 | -$8.26M(-2663.9%) | -$8.09M(>-9900.0%) | -$8.09M(>-9900.0%) |
Mar 2015 | - | -$5000.00 | -$5000.00 |
Dec 2014 | -$299.00K | - | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual cash from investing?
- What is the all-time high annual cash from investing for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual cash from investing year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly cash from investing year-on-year change?
- What is Protagonist Therapeutics, Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. TTM cash from investing year-on-year change?
What is Protagonist Therapeutics, Inc. annual cash from investing?
The current annual cash from investing of PTGX is -$299.48M
What is the all-time high annual cash from investing for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual cash from investing is $91.47M
What is Protagonist Therapeutics, Inc. annual cash from investing year-on-year change?
Over the past year, PTGX annual cash from investing has changed by -$260.23M (-662.86%)
What is Protagonist Therapeutics, Inc. quarterly cash from investing?
The current quarterly cash from investing of PTGX is $54.81M
What is the all-time high quarterly cash from investing for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly cash from investing is $57.27M
What is Protagonist Therapeutics, Inc. quarterly cash from investing year-on-year change?
Over the past year, PTGX quarterly cash from investing has changed by +$142.93M (+162.20%)
What is Protagonist Therapeutics, Inc. TTM cash from investing?
The current TTM cash from investing of PTGX is -$257.03M
What is the all-time high TTM cash from investing for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high TTM cash from investing is $115.40M
What is Protagonist Therapeutics, Inc. TTM cash from investing year-on-year change?
Over the past year, PTGX TTM cash from investing has changed by -$100.13M (-63.82%)